IGeneX Inc. offers accurate, reliable, comprehensive, and rapid testing for tick-borne illnesses, relapsing fever, and Lyme disease, and leads in research and testing development for Lyme disease and tick-borne illnesses assessment globally.
Located in Milpitas, California, IGeneX was initiated in 1991 by the leading pioneer in Lyme disease. They are focused on research and development to improve diagnostic testing methods and specificity and to increase capabilities to detect more tick-borne pathogens.
IGeneX Inc. is committed to educating patients and practitioners and facilitating collaboration with clinical practitioners to improve access to diagnosis and management of Lyme and tick-borne illnesses.
IGeneX Inc. ensures quality laboratory diagnostic testing through certification, licensing by the required agencies, and developing internal testing criteria to ensure accuracy and specificity.
IGeneX Inc. is led by experts with knowledge and research on tick-borne illnesses and Lyme disease, diagnostic testing development, and laboratory management.
iGenex offers testing for lyme disease, relapsing fever, and other tick-borne illnesses.